glp 1 agonist risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists The promise and peril of

Recurrent nocturnal hypoxic episodes promote oxidative stress and inflammatory activation, characterized by elevated TNF- , IL-6, and C-reactive protein levels (35)

Int J Obes (Lond) 2024;48(8):11181125

Understanding what these transitions look like reinforces the distinction between insulin and GLP-1 medications

Sergey Terushkin, MD, FACS Key Takeaways For decades, the field of bariatric medicine had two distinct lanes: lifestyle changes (which rarely produce massive, sustained weight loss for the morbidly obese) and bariatric surgery (which is highly effective but invasive)

Fick, M

Fadini, Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection, Curr